A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes-Reference-Cited by-同舟云学术

A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes

Published:2015-03-23 Issue:7 Volume:55 Page:831-838
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Inoue Yuichiro¹,Nakamura Akinobu¹²,Kondo Yoshinobu¹³,Hamano Kumiko⁴,Satoh Shinobu³,Terauchi Yasuo¹

Affiliation:

1. Department of Endocrinology and Metabolism; Graduate School of Medicine; Yokohama City University; Yokohama Japan

2. Division of Immunology and Metabolism, Department of Internal Medicine II; Graduate School of Medicine, Hokkaido University; Sapporo Japan

3. Department of Endocrinology and Metabolism; Chigasaki Municipal Hospital; Chigasaki Kanagawa Japan

4. Department of Diabetes and Endocrinology; Kanto Rosai Hospital; Kawasaki Kanagawa Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference45 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

2. Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials;Giugliano;Diabetes Care,2011

3. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients;Shichiri;Diabetes Care,2000

4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-depandent diabetes mellitus: a randomized prospective 6-year study;Ohkubo;Diabetes Res Clin Pract,1995

5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-Intensification from Basal-Bolus Insulin Therapy to Liraglutide in Type 2 Diabetes: Predictive Value of Mean Glycaemia during Fasting Test;Life;2024-04-28

2. Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials;Scientific Reports;2017-11-22

3. Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial;Journal of Diabetes Investigation;2017-07-10